Resumen
El síndrome de fibromialgia (FM) se caracteriza por un estado doloroso crónico, generalizado, con respuestas aumentadas a estímulos percibidos como nociceptivos, y síntomas somáticos que los pacientes localizan, sobre todo, en el aparato locomotor, sin alteraciones orgánicas demostrables. Es la causa más común de dolor musculoesquelético crónico en la población, con una prevalencia del 2%-3% de la población general, siendo su etiología desconocida. El diagnóstico de la FM es exclusivamente clínico, descartando otra razón médica aparente que justifique dichos síntomas. Es una enfermedad difícil de tratar, de forma que hasta la fecha actual ningún tratamiento farmacológico ha demostrado una eficacia suficiente para aliviar los síntomas de la enfermedad.
Palabras clave
Fibromialgia
Dolor musculoesquelético crónico
Diagnóstico clínico
Abstract
Fibromyalgia (FM) syndrome is characterised by a chronic generalised state of pain, with increased response to stimuli perceived as nociceptive, along with somatic symptoms that patients locate mainly in the locomotor system, without verifiable organic alterations. It is the most common cause of chronic musculoskeletal pain. Its prevalence is about 2%-3% in the general population and its aetiology is unknown. Diagnosis is completely clinical, excluding other apparent medical reasons that would justify the symptoms. The disease is difficult to treat, so no drug treatment has to date shown sufficient efficacy to relieve the symptoms of the condition.
Keywords
Fibromyalgia
Chronic musculoskeletal pain
Clinical diagnosis
Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[2]
JAMA., (2014), 311 pp. 1547
[4]
Improving the recognition and diagnosis of fibromyalgia.
Mayo Clin Proc., (2011), 86 pp. 457-464
[5]
Curr Pain Headache Rep., (2013 Aug), 17 pp. 356
[6]
V.A. Aparicio, F.B. Ortega, J.M. Heredia, A. Carbonell-Baeza, M. Delgado-Fernández.
Análisis de la composición corporal en mujeres con Fibromialgia.
Reumatol Clin., (2011), 7 pp. 7-12
[7]
F. Ursini, S. Naty, R.D. Grembiale.
Fibromyalgia and obesity: the hidden link.
Rheumatol Int., (2011), 31 pp. 1403-1408
[9]
J. Rivera, J. Esteve-Vives, M.A. Vallejo, I.C.A.F. Grupo.
Assessment of clinical manifestations and comorbidities in patients with fibromyalgia.
Ann Rheum Dis., (2009), 68Supp3 pp. 759
[10]
K. Fukuda, S.E. Strauss, I. Hickie, M.C. Sharpe, J.G. Dobbins, A. Komarofff, for the Chronic Fatigue Syndrome Group.
Chronic Fatigue syndrome: a comprehensive approach to its definition and study.
Ann Int Med., (1994), 121 pp. 953-959
[11]
B. Walitt, M. Čeko, M. Khatiwada, J.L. Gracely, R. Rayhan, J.W. VanMeter, et al.
Characterizing “fibrofog”: Subjective appraisal, objective performance, and task-related brain activity during a working memory task.
Neuroimage Clin., (2016), 11 pp. 173-180
[12]
O. Elkana, A.K. Falcofsky, R. Shorer, T. Bar-On Kalfon, J.N. Ablin.
Does the cognitive index of the symptom severity scale evaluate cognition? Data from subjective and objective cognitive measures in fibromyalgia.
Clin Exp Rheumatol., (2019), 37 pp. 51-57
[13]
Cognitive Impairment in Fibromyalgia: A Meta-Analysis of Case-Control Studies.
Psychosom Med., (2018), 80 pp. 432-438
[14]
E. Fuller-Thomson, J. Nimigon-Young, S. Brennenstuhl.
Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey.
Rheumatol Int., (2012), 32 pp. 853-862
[15]
M. de Tommaso, A. Federici, C. Serpino, E. Vecchio, G. Franco, M. Sardaro, et al.
Clinical features of headache patients with fibromyalgia comorbidity.
J Headache Pain., (2011), 12 pp. 629-638
[16]
S. Küçükşen, E. Genç, H. Yılmaz, A. Sallı, Gezer İA, A.Y. Karahan, et al.
The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine.
Clin Rheumatol., (2013), 32 pp. 983-990
[17]
C.H. Chen, T.Y. Yang, C.L. Lin, C.S. Chen, W.M. Lin, C.N. Kuo, et al.
Dry eye syndrome risks in patients with fibromyalgia: a national retrospective cohort study.
Medicine (Baltimore), (2016), 95 pp. e2607
[18]
F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, et al.
The American College of Rheumatology 1990 criteria for the classification of fibromyalgia.
Arthritis Rheum, (1990), 33 pp. 160-172
[19]
F. Wolfe, D.J. Clauw, M.A. Fitzcharles, D.L. Goldenberg, R.S. Katz, P. Mease, et al.
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.
Arthritis Care Res (Hoboken), (2010), 62 pp. 600-610
[20]
F. Wolfe, D.J. Clauw, M.A. Fitzcharles, D.L. Goldenberg, W. Häuser, R.L. Katz, et al.
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria.
Semin Arthritis Rheum, (2016), 46 pp. 319-329
[21]
W. Müller, M. Schneider, T. Joos, H.Y. Hsu, T. Stratz.
Subgroups of fibromyalgia.
Schmerz Berl Ger., (2007), 21 pp. 424-429
[22]
Clasificación de la fibromialgia. Revisión sistemática de la literatura.
Reumatol Clin., (2009), 5 pp. 55-62
[23]
L.H. Sigal.
Summary of the first 100 patients seen at a Lyme disease referral center.
Am J Med., (1990), 88 pp. 577-581
[24]
L.J. Leventhal, S.J. Naides, B. Freundlich.
Fibromyalgia and parvovirus infection.
Arthritis Rheum, (1991), 34 pp. 1319-1324
[25]
D. Buskila, D.D. Gladman, P. Langevitz, S. Urowitz, H.A. Smythe.
Fibromyalgia in human immunodeficiency virus infection.
J Rheumatol., (1990), 17 pp. 1202-1206
[26]
W. Häuser , J. Ablin, M.-A. Fitzcharles, G. Littlejohn, J.V. Luciano, C. Usui, et al.
Fibromyalgia.
Nat Rev Dis Primers., (2015), 1 pp. 15022
[27]
L.M. Arnold, J.I. Hudson, E.V. Hess, A.E. Ware, D.A. Fritz, M.B. Auchenbach, et al.
Family study of fibromyalgia.
Arthritis Rheu, (2004), 50 pp. 944-952
[28]
D. Buskila, P. Sarzi-Puttini, J.N. Ablin.
The genetics of fibromyalgia syndrome.
Pharmacogenomics., (2007), 8 pp. 67-74
[29]
R. Markkula, P. Järvinen, P. Leino-Arjas, M. Koskenvuo, E. Kalso, J. Kaprio.
Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort.
Eur J Pain [Internet]., (2009), 13 pp. 744-750
[30]
Reumatol Clin., (2020), 16 pp. 191-194
[31]
R.H. Gracely, F. Petzke, J.M. Wolf, D.J. Clauw.
Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.
Arthritis Rheum, (2002), 46 pp. 1333-1343
[32]
J. Pujol, C. Soriano, J. Bofill, E. Cámara, A. Villanueva, N. Cardoner, et al.
Resonancia magnética funcional de la respuesta cerebral al dolor en pacientes con diagnóstico de fibromialgia.
Psiquiat Biol., (2006), 13 pp. 39-46
[33]
J. Pujol, M. López-Sola, H. Ortiz, J.C. Vilanova, B.J. Harrison, M. Yücel, et al.
Mapping brain response to pain in Fibromialgia patients using temporal analysis of FMRI.
PLoS ONE, (2009), 4 pp. e5224
[35]
J. Wikner, U. Hirsch, L. Wetterberg, S. Röjdmark.
Fibromyalgia - A syndrome associated with decreased nocturnal melatonin secretion.
Clin Endocrinol (Oxf)., (1998), 49 pp. 179-183
[36]
D. Mendieta, D.L. de la Cruz-Aguilera, M.I. Barrera-Villalpando, E. Becerril-Villanueva, R. Arreola, E. Hernández-Ferreira, et al.
IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients.
J Neuroimmunol [Internet], (2016), 290 pp. 22-25
[37]
D. Malhotra, A.K. Saxena, S.A. Dar, V. Kumar, N. Nasare, A.K. Tripathi, et al.
Evaluation of cytokine levels in fibromyalgia syndrome patients and its relationship to the severity of chronic pain.
J Musculoskelet Pain., (2012), 20 pp. 164-169
[38]
G. Prados, E. Miró, M.P. Martínez, A.I. Sánchez, S. López, G. Sáez.
Fibromyalgia: gender differences and sleep-disordered breathing.
Clin Exp Rheumatol., (2013), 31 pp. S102-S110
[39]
A.A. Maafi, B. Ghavidel-Parsa, A. Haghdoost, Y. Aarabi, A. Hajiabbasi, I. Shenavar Masooleh, et al.
Serum vitamin D status in iranian fibromyalgia patients: according to the symptom severity and illness invalidation.
Korean J Pain., (2016), 29 pp. 172
[40]
D. Daniel, M.V. Pirotta.
Fibromyalgia--should we be testing and treating for vitamin D deficiency?.
Aust Fam Physician., (2011), 40 pp. 712
[41]
Síndrome de fatiga crónica. Documento de consenso.
Aten Primaria., (2009), 41 pp. 529-531
[42]
L.A. Aaron, M.M. Burke, D. Buchwald.
Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.
Arch Intern Med., (2000), 160 pp. 221
[44]
G.J. Macfarlane , C. Kronisch, F. Atzeni, W. Häuser, E.H. Choy, K. Amris, et al.
EULAR recommendations for management of fibromyalgia.
Ann Rheum Dis., (2017), 76 pp. e54
[45]
Recomendaciones SER sobre el manejo de los pacientes con fibromialgia 2020. Disponible en: https://www.ser.es/recomendaciones-sobre-fibromialgia-fm/.
[46]
EULAR revised recommendations for the management of fibromyalgia.
Ann Rheum Dis., (2017), 76 pp. 318-328
